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abstract
CONTEXT: There are today only a limited number of studies defining
growth parameters and nutritional status for HIV children.
OBJECTIVE: To study the nutritional status of infants infected with the
human immunodeficiency virus.
TYPE OF STUDY: Longitudinal study.
SETTING: Department of Pediatrics, Faculty of Medical Sciences,
UNICAMP, Campinas, Brazil.
PARTICIPANTS: One hundred and twenty-four children born to HIV
infected mothers were evaluated from birth until the age of two years.
They were subdivided into two groups: 71 infected children and 53
non-infected children.
MAIN MEASUREMENTS: Growth was evaluated in both groups
by comparing Z-scores for weight/age (W/A), length/age (H/A)
and weight/length (W/H) (using the NCHS curves as reference).
RESULTS: The Z-score analyses showed that there was a significant
difference between the two groups for all the variables studied, ex-
cept for the H/A value at 3 months of age and the W/H value at 21
months of age, which showed P > 0.05.
CONCLUSIONS: The growth of infected infants was observed to be
severely affected in comparison with that of seroreversed infants in
the same age groups. Although clinical manifestations may take time
to appear, the onset of growth changes begin soon after birth.
KEY WORDS: Growth and development. Nutritional status. Chil-
dren. HIV. Acquired immunodeficiency syndrome.
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INTRODUCTION
AIDS has caused a tremendous impact ever since
the first adult and child cases were reported at the
Center for Disease Control, Atlanta, USA1 and has be-
come one of the greatest health problem all over the
world. According to the estimates in 1994, there were
approximately 2 million children infected with HIV in
the world. In the United States of America, there are
12,000 infected children.2
As the number of heterosexual men infected in-
creased, the number of women and children infected also
increased. In 1985, the highest number of AIDS cases
reported was among homosexuals followed by bisexu-
als, drug addicts and lastly heterosexuals. In 1987, most
of the cases reported were heterosexuals, followed by
homosexuals and endovenous drug addicts.3 Conse-
quently, the number of cases of AIDS in children in-
creased. There was an improvement in the notification
of cases when pre-natal follow-up of the mothers was
conducted with later follow-up of the children. In com-
parison with the 1990’s, the number of infected women
has increased and as a result the number of infected chil-
dren has also risen. In September 1993, there were 4,906
pediatric cases of AIDS diagnosed in the United States –
88% were due to perinatal transmission from the infected
mother and 11% were as a result of contaminated blood
transfusions.4 According to the World Health Organiza-
tion, by the year 2000, approximately 40 million adults
and 2 million children will have been infected with HIV.5
In Brazil, the first cases of AIDS in children were
reported in 1983 and almost all of them were infected by
blood transfusions or by the transfusion of its derivatives.3
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Up to August 1998, there had been 140,362 cases
of AIDS reported in Brazil. Of these, 4815 (3.4%) were
children below the age of 13, which demonstrated that
in this age group there had been an increase in this
disease. Among infant cases, 3825 (79.4%) acquired the
disease through vertical transmission, 205 (4.3%) were
hemophiliacs, 279 (5.8%) acquired it through transfu-
sions and 489 (10.2 %) from unknown sources, and 1986
(41.2%) of these infant cases had died.3
The clinical manifestations generally shown by such
children are: generalized lymphadenopathy, hepatosple-
nomegaly, oral candidiasis and recurring infections.6-9
There are today only a limited number of studies
defining growth parameters for HIV children.10,11 Halsey,
et al.12 (1990), studied a population sample in Haiti and
found that the weight of the babies born to mothers
positive for HIV type were similar, independent of the
state of infection during that period, but different from
the weight of babies born to mothers negative for HIV
type. Although the ingestion of nutrients and the body
mass were not reported, the weight of children positive
for HIV at 3 months differed from the weight of children
seronegative for HIV and the HIV negative control group.
Miller, et al.10 (1993) observed that at birth, normal chil-
dren and HIV infected children had similar weight, ges-
tational age and percentile weight but at between 19
and 21 months, their percentile weights differed sig-
nificantly and the lengths remained the same.
McKinney, et al.11 (1993) analyzed the growth rate of
children during the first two years of life and found that
the growth index of HIV infected children during the
first four months was significantly less than that of non-
infected children regarding weight as well as length in
relation to age and that the linear growth as well as the
gain in weight were proportionally reduced. Moye, et
al.13 (1996) studied the magnitude of the infection
caused by the human immunodeficiency virus, acquired
either perinatally or congenitally, on somatic growth
from birth up to the age of 18 months. They concluded
that the infected children showed a progressive decline
in body mass index from birth to the age of 6 months.
Growth monitoring is an important tool for evalu-
ating the child’s health. We were able to study this ques-
tion profoundly because of the information available
regarding the weight and length of seroreversed infected
children, who were being treated at the Outpatient Pe-
diatrics Department, Hospital das Clínicas, State Uni-
versity of Campinas, SP, Brazil. The objective of this re-
search was to study the nutritional status with regard
to weight and length of children with the human im-
munodeficiency virus aged zero to 24 months, and to
compare these results with those of non-infected chil-
dren with mothers who were positive for HIV.
METHODS
The procedures that follow were in accordance
with the ethical standards of the committee respon-
sible for human experimentation and with the Helsinki
declaration of 1975, as revised in 1993.
Table 1. Characteristics of the population studied
Children
Characteristics Infected (n = 71) Non-infected (n = 53) Total (n = 124)
No. % No. % No. %
Sex
Male 34 47.9 31 58.5 65 52.4
Female 37 52.1 22 41.5 59 47.6
Situation
Follow-up 32 45.1 30 56.6 62 50
Discharged - - 12 22.6 12 9.7
Died(*) 23 32.4 - - 23 18.5
Abandoned 13 18.4 10 18.8 23 18.6
Transferred 3 4.2 1 1.9 23 3.2
Mother’s education (**)
Middle school complete 5 9.4 - - 5 5.7
Middle school incomplete 35 66.0 27 79.4 62 71.3
High school complete 6 11.3 4 11.8 10 11.5
High School incomplete 3 5.7 2 5.9 5 5.7
University 4 7.5 1 2.9 5 5.7
Childbirth (***)
Cesarean 23 35.9 19 38.8 42 37.2
Vaginal 41 64.1 30 61.2 71 62.8
Breast feeding (****)
Yes 41 64.1 19 37.3 60 52.2
No 23 35.9 32 62.7 55 47.8
(*)   13 children died before the age of 2 years and 10 children after the age of 2 died; (**) 37 dossiers did not furnish this information; (***) 11
dossiers did not furnish this information, (****) 9 dossiers did not furnish this information.
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Table 2. Infected and non-infected children according to their weight and length at birth and their gestational age
Children Weight at birth (kg) Length at birth (cm) Gestational age (weeks)
Infected n = 59* n = 36* n = 29*
Mean 2.95 48.6 39.4
SD 0.69 2.85 1.70
Median 2.90 48.5 40.0
Non-infected n = 38* n = 33* n = 25*
Mean 2.95 48.6 39.3
SD 0.69 2.62 1.98
Median 2.92 49.0 40.0
Total (n = 124) n = 97* n = 69* n = 54*
Mean 2.95 48.6 39.3
SD 0.68 2.72 1.82
Median 2.90 49.0 40.0
*Patients whose information was available; sd = standard deviation.
Design
A mixed longitudinal study was conducted dur-
ing the follow-up period from August 1985 to April 1996.
Setting
Department of Pediatrics, State University of
Campinas.
Participants
Children whose mothers were found to be posi-
tive for HIV at the Outpatient Department, Pediatric Im-
munodeficiency Service, Hospital das Clínicas, State
University of Campinas. The following variables were
analyzed: age, sex, gestational age at birth, weight at
birth, weight and length during the follow-up period.
The study was conducted on 124 patients who fulfilled
the criteria established. Children who weighed less than
2500g and those who started treatment after the age of
two years were excluded.
The criteria for inclusion were:
a) Born after full gestational term and with weight ≥
2500 g.16
b) Absence of congenital diseases that could interfere in
the development of the child and its nutritional state.
c) Only vertically infected children were included
(mother → child).
The children were classified into two groups:
a) Infected Children: those children who were serologi-
cally positive for the human immunodeficiency vi-
rus after conducting the enzyme-linked
immunoabsorbent assay (ELISA) and confirmed by
the Western Blot or Immunofluorescence test after
the age of 18 months or before this date, if the child
showed symptoms of the disease.
b) Non-infected Children (seroreversed): the children were
considered to be non-infected when they showed
a complete reversal of the serological results
(ELISA) up to 18 months of age, with normal im-
munology and without any symptoms of the hu-
man immunodeficiency virus infection.
Main Measurements
Anthropometry. A nutritional evaluation was con-
ducted with the help of weight and length measure-
ments and utilizing the curves of the “National Center
for Health Statistics”,14 which have been recommended
by the World Health Organization (WHO). The relation-
ships weight/length, length/age and weight/age were ex-
pressed in terms of “Z-scores”.15 In order to analyze the
Z scores, children between the ages of zero and 24
months and infected with the human immunodeficiency
virus were chosen, and also children between zero and
24 months who were seropositive at the beginning and
became negative by the age of 18 months.
Statistical Methods
The Student T test was used in the case of indepen-
dent samples when the normality supposition was satis-
fied and the Mann-Whitney U test was used for the rest.
The tests were conducted for a 5% significance (α) level.
The patients were classified according to their
ages for statistical analysis:
a) Between 0 and 6 months: The measurements clos-
est to three months were taken for the calculation
of the Z-scores.
b) Between 6 and 12 months: The measurements clos-
est to nine months were taken for the calculation of
the Z-scores.
c) Between 12 and 18 months: The measurements clos-
est to fifteen months were taken for the calculation
of the Z-score.
d) Between 18 and 24 months: The measurements clos-
est to twenty-four months were taken for the calcu-
lation of the Z-score.
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Z-scores were calculated for weight/age, length/
age and weight/length in the cases of both the infected
and the non-infected groups of children.
RESULTS
The children were divided into two groups – in-
fected and non-infected – and classified according to
their sex, color, mother’s education, type of birth and
whether they were breast-fed (Table 1).
It was observed that with regard to the sex of chil-
dren in the infected group, 34 children (47.9%) were male
and 37 (52.1%) were female. In the case of non-infected
children, 31 (58.5%) were males and 22 (41.5%) were
females. During the survey period, the follow-up ser-
vice at the Pediatric Immunodeficiency Department was
regularly used by 32 infected children (45.1%); 13 chil-
dren (18.4%) abandoned the follow-up; 3 children (4.2%)
were transferred to another service and 23 children
(32.4%) died. Thirteen of the children (56.5%) who died
did so before the age of 2, and 10 children (43.4%) died
after the age of 2. The infected children reported at the
clinic according to the evolution of the disease, which
was usually weekly. In the group of non-infected chil-
dren, 30 children (56.6%) had a regular follow up, 10
children (18.8%) abandoned the program, 1 child (1.9%)
was transferred to another program and 12 (22.6%) chil-
dren were discharged. None of the children from this
group died. Most of the children came from a back-
ground of low income and mother’s education.
Table 2 shows the distribution of the children in
the infected and non-infected groups with regard to the
weight and length at birth and gestational age.
It was verified that the weight and length at birth
and the gestational age were similar for the two groups.
The results of the Z-score analyses are shown in
Table 3. It can be seen that there is a difference be-
tween all the variables for both groups except in the
case of length/age at 3 months and weight/length at 21
months as the value obtained for P was > 0.05.
DISCUSSION
The analysis of the growth of children born to
HIV+ mothers reveals the social and affective factors
involved in these children’s families. Children of HIV+
mothers are raised in an environment highly affected
by the disease and the circumstances that follow it. The
children that develop infection have a path of highs and
lows depending of the availability of the treatment and
the response that each patient presents to this treat-
ment. This work refers to children treated before the
recently proposed drug therapy, and the objective of
this study was not, at this time, to evaluate the effect of
clinical treatment on the patients.
HIV can be transmitted vertically during pregnancy,
at birth and or during breast feeding. According to the
clinical data, at least 50% of the transmissions seem to
occur at birth. This supposition is based on the fact that
in the case of most children, it is difficult to detect viral
particles during the first weeks of life without the viral
multiplication or the formation of antibodies which oc-
curs around the second month.17 It is probably at this
stage that the virus comes out of latency and begins the
phase of viral replication which is proportional to the
stimulus offered by the immune system.
Children born to mothers who are seropositive
for HIV, are usually born seropositive because of the
Table 3. Z-score values for the infected and non-infected groups
of children according to the anthropometric index and age
Children
Group Infected Non-Infected P-value
Z-score n Mean SD Median n Mean SD Median
H/A - 3 months 21 -1.37 1.16 -1.35 30 -0.98 1.30 -0.78 0.1652 (**)
H/A -9 months 25 -2.46 1.16 -2.49 28 -0.91 1.26 -0.89 0.0000(*)
H/A - 15 months 28 -2.59 1.46 -2.76 29 -1.06 0.96 -0.88 0.0000(*)
H/A - 21 months 37 -2.12 1.48 -2.51 25 -0.59 1.19 -0.37 0.0001(*)
W/H - 3 months 21 -0.39 0.82 -0.62 30 0.73 1.87 0.31 0.0005 (*) (**)
W/H - 9 months 25 -0.95 1.17 -0.76 28 -0.03 0.99 0.10 0.0033(*)
W/H - 15 months 28 -0.86 1.06 -0.86 29 -0.22 1.04 -0.06 0.0249(*)
W/H - 21 months 37 -0.66 1.25 -0.57 25 -0.39 1.07 -0.62 0.3747
W/A - 3 months 22 -1.35 1.05 -1.37 30 -0.47 1.15 -0.41 0.0067(*)
W/A - 9 months 26 -2.50 1.35 -2.40 28 -0.78 1.07 -0.61 0.0000(*)
W/A - 15 months 28 -2.28 1.38 -2.37 29 -0.85 0.85 -0.93 0.0000(*)
W/A - 21 months 39 -1.69 1.46 -1.75 26 -0.62 1.10 -0.85 0.0030(*)
(*)  There is evidence that a difference exists; (**) The Mann-Whitney test was used; H/A = length/age; W/H = weight/length; W/A = weight/age.
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resumo
CONTEXTO: Atualmente há estudos limitados que definem parâmetros
de crescimento e estado nutricional em crianças com HIV.
OBJETIVO: Estudar o estado nutricional de crianças infectadas com
o vírus da imunodeficiência humana.
TIPO DE ESTUDO: Estudo longitudinal.
LOCAL: Serviço de imunodeficiência pediátrica da Universidade
Estadual de Campinas, Campinas, Brasil.
PARTICIPANTES: 124 crianças nascidas de mulheres infectadas com
o HIV foram avaliadas desde o nascimento até dois anos de idade.
Elas foram subdivididas em dois grupos: 71 crianças infectadas e
53 crianças não-infectadas.
PROCEDIMENTOS: A avaliação do estado nutricional foi realizada pela
comparação do Z-score para peso/idade(P/I),altura/idade(A/I) e peso/
altura(P/A),usando as curvas do NCHS como referência. Para a
comparação do Z-score foram utilizados os testes T de Student e U de
Mann-Whitney. Os testes foram conduzidos ao nível de significância=5%.
RESULTADOS: A análise do Z-score revelou que houve evidência
de diferença entre os dois grupos, para todas as variáveis estudadas,
exceto o índice de A/I aos 3 meses e P/A aos 21 meses.
CONCLUSÕES: O estado nutricional das crianças infectadas foi grave-
mente afetado em comparação com as crianças sororreversoras no mes-
mo grupo de idade. Embora as manifestações clínicas possam demorar
a aparecer, as alterações no crescimento surgem logo após o nascimento.
PALAVRAS-CHAVE: Crescimento e desenvolvimento. Estado
nutricional. Crianças. HIV. Síndroma da imunodeficiência adquirida.
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